
Anticoagulation in the HeartMate 3 Left Ventricular Assist Device: Are We Finally Moving the Needle?
Author(s) -
Song Li,
Claudius Mahr
Publication year - 2022
Publication title -
asaio journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.961
H-Index - 66
eISSN - 1538-943X
pISSN - 1058-2916
DOI - 10.1097/mat.0000000000001689
Subject(s) - medicine , apixaban , dabigatran , edoxaban , warfarin , rivaroxaban , ventricular assist device , adverse effect , atrial fibrillation , heart failure , vitamin k antagonist , population , randomized controlled trial , direct thrombin inhibitor , intensive care medicine , cardiology , destination therapy , environmental health